|
17.12.2024 02:29:16
|
Jazz Pharma CEO Bruce Cozadd To Retire
(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) said that its Co-Founder, Chairperson and Chief Executive Officer, Bruce Cozadd, plans to retire from his role as Chief Executive Officer upon appointment of the Company's next leader, expected by the end of 2025. Cozadd will continue serving as Chairperson of the Board of Directors.
The Board will commence a formal search process to identify a new Chief Executive Officer, which is anticipated to conclude within 12 months.
Jazz said it remains on track to meet its full year 2024 total revenue guidance of between $4.0 billion and $4.1 billion. Analysts polled by Thomson Reuters expect the company to report revenues of $4.04 billion for fiscal year 2024. Analysts' estimates typically exclude special items.
Analysen zu Jazz Pharmaceuticals PLC
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Meta Platforms
NEU✅ Microsoft
inklusive Rebalancing:
❌ Arthur J. Gallagher & Co
❌ Progressive
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| Jazz Pharmaceuticals PLC | 112.75 | 0.16% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Wall Street gespalten -- SMI schliesst im Plus -- DAX zum Handelsende fester -- Börsen in Fernost letztlich uneinig - Nikkei stabilDer heimische und der deutsche Aktienmarkt präsentierten sich zur Wochenmitte freundlich. Die US-Börsen finden zur Wochenmitte keine gemeinsame Richtung. Auch die asiatischen Indizes gaben indes überwiegend nach, lediglich der Nikkei hielt sich knapp im Plus.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |